✦ LIBER ✦
TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-β treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response
✍ Scribed by Mathias Buttmann; Cornelia Merzyn; Harald H. Hofstetter; Peter Rieckmann
- Book ID
- 113730153
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 278 KB
- Volume
- 190
- Category
- Article
- ISSN
- 0165-5728
No coin nor oath required. For personal study only.